Majid, Bayanan C.
HRN: 23-13-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/09/2023
06/16/2023
IV
1.5gm
Q6
CAP MR
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes